Evidence map›Paper›PMID 35393277›Full record

ArticleBMJ case reports2022

Left cheek sclerosing rhabdomyosarcoma and development of isolated free flap donor site metastasis.

Deborah Zhou, Vivek Bhadri, Peter Luk, Sydney Ch'ng, Daniel Franks, Angela Hong

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Deborah ZhouDepartment of Medical Oncology, Chris O'Brien Lifehouse, Camperdown, New South Wales, Australia.ORCID http://orcid.org/0000-0001-5918-4439
Vivek BhadriDepartment of Medical Oncology, Chris O'Brien Lifehouse, Camperdown, New South Wales, Australia.
Peter LukDepartment of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.
Sydney Ch'ngThe University of Sydney, Sydney, New South Wales, Australia.
Daniel FranksDepartment of Orthopaedics Surgery, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.
Angela HongThe University of Sydney, Sydney, New South Wales, Australia angela.hong@sydney.edu.au.
The University of Sydney · AURoyal Prince Alfred Hospital · AUChris O’Brien Lifehouse · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rhabdomyosarcoma is a rare mesenchymal malignancy with four different morphological subtypes: alveolar, embryonal, pleomorphic and spindle cell/sclerosing. It is the most common soft tissue sarcoma of children and adolescents but occurs less commonly in adults. We describe a male patient in his 20s with sclerosing rhabdomyosarcoma of the left cheek who developed an isolated free flap donor site metastasis in the first instance but subsequently progressed with bilateral pulmonary metastases. Multidisciplinary team involvement in a sarcoma specialist centre is essential and collaboration between the pathologist, radiologist, head and neck surgeon, orthopaedic surgeon, radiation oncologist and medical oncologist were integral in providing optimal management in this patient. Furthermore, this case report highlights this phenomenon of implantation metastasis in a patient with rhabdomyosarcoma, and emphasises the importance of surgical barriers between the resection and reconstruction teams in an oncological case.

Indexed as

Free Tissue FlapsRhabdomyosarcomaRhabdomyosarcoma, EmbryonalSoft Tissue NeoplasmsAdolescentAdultCheekChildHumansMaleOncologySurgical oncology

Identifiers

PMID35393277
PMCPMC8990714
OpenAlexW4223419418

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.